AVITA MEDICAL CDI 5:1 (AVH) Short Interest
AVITA MEDICAL CDI 5:1 (ASX:AVH) had 0.40% of shares reported as short positions as of 16 May 2026, representing 340,072 shares. AVITA MEDICAL CDI 5:1 operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.40%
- Reported positions
- 340,072
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
AVH
Avita Medical Inc.
Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.